A correlation has also been observed in ESCC tissues between higher levels of IL-33 and increased density of stromal FoxP3+ Tregs [93], which are thought to enhance tumor progression attenuating the host immune response against ESCC [94,95] (Figure 4b). The gene discussed is IL33; the disease is neoplasm.